Autres langues AstraZeneca PLC NYSE

Actions

AZN

US0463531089

Produits pharmaceutiques

Temps réel estimé Cboe BZX 17:46:44 21/09/2026			Varia. 5j.	Varia. 1 janv.
167,88 ^USD	+1,09 %		+3,69 %	+81,87 %

15:53	Le secteur pharmaceutique mise sur l'IA pour réduire ses coûts et ses délais	RE
14:10	Les développeurs de traitements contre l'obésité se bousculent pour conquérir un marché lucratif face à une concurrence accrue	RE

Autres langues

15:53	Pharma sector doubles down on AI to slash costs, timelines
14:10	Weight-loss drug developers line up to tap lucrative market as competition heats up
13:36	AstraZeneca And Daiichi Sankyo Receive CHMP Recommendation For Enhertu As Adjuvant Treatment For HER2-Positive Early Breast Cancer In The EU
12:46	University of Dundee: Tayside team recruit first global participant in clinical trial for Chronic Kidney Disease
11:06	Two favorable EU opinions for AstraZeneca
11:05	AstraZeneca PLC Klygefa Recommends For EU Approval By CHMP
10:44	Europe's STOXX 600 rises on tech rally, easing oil prices
09:52	El europeo STOXX 600 sube ante el repunte del sector tecnológico y el retroceso del petróleo
09:28	Europe's STOXX 600 gains as tech rallies, oil retreat eases nerves
07:01	Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs
18/09	Alexion Biologics License Application for Efzimfotase Alfa Accepted and Granted Priority Review by Us Fda for Treatment of Patients with Hypophosphatasia Aged 2 Years and Older
18/09	European Stocks Close Sharply Lower in Friday Trading as Middle East Fighting Continues to Choke Oil Supply
18/09	FTSE 100 slides as bond yields resume upward path
18/09	UK Stocks End Week Lower; Retail Sales Unexpectedly Rise
18/09	AstraZeneca drug Klygefa gains positive opinion from EU's CHMP
18/09	AstraZeneca's Alexion Gets Positive EU Recommendation for Klygefa in Rare Muscle Disease
18/09	EU Medicines Agency Panel Backs Indication Extension for AstraZeneca, Daiichi Sankyo's Breast Cancer Drug
18/09	AstraZeneca : Klygefa (gefurulimab) recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis (gMG)
18/09	AstraZeneca, Daiichi celebrate another recommended approval of Enhertu
18/09	AstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2 Positive Breast Cancer
18/09	AstraZeneca's Alexion Wins European Medicines Agency Panel's Positive Opinion for Autoimmune Disease Drug
18/09	FTSE 100 falls as Airtel Africa tumbles
18/09	AstraZeneca chief executive buys GBP7 million in shares
18/09	Big Picture Bio Founded to Identify, Design and Optimise Promising Cancer Combination Therapies
18/09	Onco360(R) Has Been Selected as a National Pharmacy Partner for ETCAMAH (camizestrant)